Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...

Flagship Harbor Advisors LLC acquired a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

Tandem Diabetes Care, Inc.’s TNDM impressive strategic initiatives are expected to bolster growth in the upcoming quarters. A ...

In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target ...

In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Insulet announces the launch of Omnipod 5 in five more countries in Europe, Italy, Denmark, Finland, Norway and Sweden.

Omnipod 5 is available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (“CGM”) sensor compatibility. The latest development represents a significant ...

"Dexcom made key strategic investments in 2024," said CEO Kevin Sayer, adding the company plans to build on these investments in 2025 by advocating for greater CGM access globally. The company is ...